|
Canepa M, Patel NR, Griffith RC, Ng TT, Azzoli CG.
"KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 14, no. 7, 2019, pp. e153-e155.
|
|
Pennell NA, Neal JW, Chaft JE, Azzoli CG, Jänne PA, Govindan R, Evans TL, Costa DB, Wakelee HA, Heist RS, Shapiro MA, Muzikansky A, Murthy S, Lanuti M, Rusch VW, Kris MG, Sequist LV.
"SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer." Journal of Clinical Oncology, vol. 37, no. 2, 2019, pp. 97-104.
|
|
Piotrowska Z, Costa DB, Oxnard GR, Huberman M, Gainor JF, Lennes IT, Muzikansky A, Shaw AT, Azzoli CG, Heist RS, Sequist LV.
"Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions." Annals of Oncology, vol. 29, no. 10, 2018, pp. 2092-2097.
|
|
Farago AF, Azzoli CG.
"Beyond <i>ALK</i> and <i>ROS1: RET, NTRK, EGFR</i> and <i>BRAF</i> gene rearrangements in non-small cell lung cancer." Translational lung cancer research, vol. 6, no. 5, 2017, pp. 550-559.
|
|
Li BT, Drilon A, Johnson ML, Hsu M, Sima CS, McGinn C, Sugita H, Kris MG, Azzoli CG.
"A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers." Annals of Oncology, vol. 27, no. 1, 2016, pp. 154-9.
|
|
Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG.
"Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 11, no. 4, 2016, pp. 537-44.
|
|
Gainor JF, Shaw AT, Sequist LV, Fu X, Azzoli CG, Piotrowska Z, Huynh TG, Zhao L, Fulton L, Schultz KR, Howe E, Farago AF, Sullivan RJ, Stone JR, Digumarthy S, Moran T, Hata AN, Yagi Y, Yeap BY, Engelman JA, Mino-Kenudson M.
"EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis." Clin Cancer Res , vol. 22, no. 18, 2016, pp. 4585-93.
|
|
Azzoli CG.
"Practical Value of Molecular Pathology in Stage I-III Lung Cancer: Implications for the Clinical Surgeon." Annals of Surgical Oncology, vol. 22, no. 11, 2015, pp. 3459-65.
|
|
Azzoli CG, Engelman J, Fidias P, Gainor JF, Heist RS, Lamont EB, Lennes IT, Rosovsky RP, Sequist LV, Shaw AT, Temel JS.
"Genotyping lung cancer is an investment in the future." Journal of Clinical Oncology, vol. 32, no. 31, 2014, pp. 3576-7.
|
|
Chaft JE, Litvak A, Arcila ME, Patel P, D'Angelo SP, Krug LM, Rusch V, Mattson A, Coeshott C, Park B, Apelian DM, Kris MG, Azzoli CG.
"Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation." Clinical lung cancer, vol. 15, no. 6, 2014, pp. 405-10.
|
|
Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.
"Benefits and harms of CT screening for lung cancer: a systematic review." JAMA, vol. 307, no. 22, 2012, pp. 2418-29.
|
|
D'Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, Shen R, Zheng J, Dycoco J, Kris MG, Zakowski MF, Ladanyi M, Rusch V, Azzoli CG.
"Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 7, no. 12, 2012, pp. 1815-1822.
|
|
Azzoli CG, Patel JD, Krug LM, Miller V, James L, Kris MG, Ginsberg M, Subzwari S, Tyson L, Dunne M, May J, Huntington M, Saunders M, Sirotnak FM.
"Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 6, no. 11, 2011, pp. 1915-22.
|
|
Azzoli CG, Baker S Jr, Temin S, Pao W, Aliff T, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, Nordquist L, Pfister DG, Piantadosi S, Schiller JH, Smith R, Smith TJ, Strawn JR, Trent D, Giaccone G, American Society of Clinical Oncology.
"American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer." Journal of Clinical Oncology, vol. 27, no. 36, 2009, pp. 6251-66.
|
